Impact BioMedical, Inc. (IBO)
Impact BioMedical, Inc. is a biotechnology company that develops and manufactures medical devices and products primarily for wound care, surgical, and regenerative applications. The company focuses on innovative solutions to improve patient outcomes, including advanced wound dressings and dermal fillers.
Company News
DSS, Inc. announced that its subsidiary, Impact BioMedical Inc., has entered into a definitive merger agreement with Dr. Ashleys Limited, a global pharmaceutical company. The transaction will result in a newly formed combined entity traded on the NYSE American under the name 'Dr Ashleys Limited'.
Impact BioMedical Inc. announced that there has been no material development in its business affairs not previously disclosed or any other reason to account for the unusual market action regarding its share price.